02576.HK
Zhejiang Taimei Medical Technology Co., Ltd.
HKSE · Technology · Software - Application · CN
HKD 4.14
−5.69%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.1%
- EBITDA
- +83.8%
- EBIT
- +75.6%
- Net income
- +80.6%
- EPS
- +81.0%
- Free cash flow
- +79.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026